Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 154,868 | 185,636 | 210,709 | 248,226 | 207,457 |
| Marketable Securities | 499 | 499 | 393 | 3,393 | 18,438 |
| Receivables | 32,285 | 29,629 | 8,320 | 9,532 | 18,920 |
| Inventories | N/A | N/A | 1,674 | 2,468 | 5,315 |
| Other current assets | 7,523 | 9,665 | 14,753 | 16,733 | 22,257 |
| TOTAL | $195,175 | $225,429 | $235,849 | $280,352 | $272,387 |
| Non-Current Assets | |||||
| PPE Net | 76,523 | 78,846 | 80,542 | 79,478 | 75,403 |
| Intangibles | 1,698 | 1,854 | 2,551 | 1,584 | 1,604 |
| Other Non-Current Assets | 73,794 | 75,947 | 93,944 | 96,151 | 93,318 |
| TOTAL | $152,015 | $156,647 | $177,037 | $177,213 | $170,325 |
| Total Assets | $347,191 | $382,076 | $412,886 | $457,565 | $442,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,607 | 2,354 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 20,921 | 23,762 | 22,809 | 28,254 | 24,682 |
| Other current liabilities | 9,820 | 14,602 | 18,214 | 15,078 | 14,991 |
| TOTAL | $52,337 | $49,348 | $49,603 | $51,446 | $46,922 |
| Non-Current Liabilities | |||||
| Long Term Debt | 18,345 | 20,030 | 22,767 | 23,475 | 27,990 |
| Deferred Revenues | 581 | 301 | 500 | 423 | 264 |
| Other Non-Current Liabilities | 76,301 | 79,308 | 81,026 | 82,012 | 81,534 |
| TOTAL | $91,800 | $96,255 | $101,135 | $103,796 | $106,046 |
| Total Liabilities | $144,137 | $145,602 | $150,739 | $155,243 | $152,969 |
| Shareholders' Equity | |||||
| Common Shares | 2,945 | 2,945 | 2,946 | 2,947 | 2,801 |
| Retained earnings | -727,973 | -698,326 | -675,924 | -638,071 | -598,207 |
| Other shareholders' equity | -9,251 | -2,841 | 9,835 | 16,856 | 15,454 |
| TOTAL | $203,054 | $236,474 | $262,147 | $302,323 | $289,744 |
| Total Liabilities And Equity | $347,191 | $382,076 | $412,886 | $457,566 | $442,713 |